We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Upholds Pfizer Patent, Blocks Generic Xalatan

Law360 (August 14, 2005, 12:00 AM EDT) -- Pfizer Inc.’s glaucoma drug Xalatan is off limits to generics manufacturer Par Pharmaceutical Inc., following a decision in Pfizer’s favor by the U.S. Court of Appeals for the Federal Circuit....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.